Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Chiltern establishes new office in Netherlands
Chiltern is a clinical contract research organization (CRO) with experience in the management of Phase I-IV clinical trials across a range of therapeutic areas, functional service provision and
Chiltern is a clinical contract research organization (CRO) with experience in the management of Phase I-IV clinical trials across a range of therapeutic areas, functional service provision and
MyKidz Iron products are liquid supplements that help reduce the staining of teeth associated with iron. Three formulations – MyKidz Iron, MyKidz Iron 10 and MyKidz Iron FL
GE Healthcare claims that Centricity Research facilitates various institutions in conducting clinical or translational research and manages the growing complexity of research processes and compliance requirements. The platform
Telstar is a multinational group based in Spain that develops technology projects, equipment and services in the biotechnology, nanotechnology, traditional technology and medicine fields. With this agreement, Telstar
PPD claims the new application offers advanced keyword search menus and allows the users to customize their search in terms of location, gender, age and other search criteria
Under the agreement, Emerald and ChemDiv will use their transitional and integrated drug discovery and development platform to support collaborative efforts. ChemDiv Biology CTO and vice president Ilya
With this acquisition, Oncodesign’s clients are now eligible to access the entire collection to assess therapeutic compounds in house or to carry out preclinical studies with Oncodesign. The
Phlexglobal is a specialist global contract research organisation (CRO), delivers clinical research support solutions to meet its clients’ needs through its five core services of resourcing, task force,
Watson claims that its Oxycodone Hydrochloride extended-release tablets are the generic version of Purdue Pharma’s treatment, OxyContin for the management of moderate to severe when continuous, around-the-clock opioid
Under the contract, TPP and the University of Aberdeen expect to work on the commercialization opportunities in the areas of nervous system disorders, immunology/inflammation and oncology. University of